<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-pathogens-09-00137">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pas</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Streefkerk</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Pronk</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De Man</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Beersma</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Van Der Eijk</surname>
    <given-names>A.A.</given-names>
   </name>
  </person-group>
  <article-title>Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients</article-title>
  <source>J. Clin. Virol.</source>
  <year>2013</year>
  <volume>58</volume>
  <fpage>629</fpage>
  <lpage>634</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jcv.2013.10.010</pub-id>
  <pub-id pub-id-type="pmid">24210958</pub-id>
 </element-citation>
</ref>
